US Bancorp
AST.WS

US Bancorp’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

US Bancorp’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-137
Closed – – 3767
2017
Q2 		$0 Hold
137
– – ﹤0.01% 3738
2017
Q1 		$0 Hold
137
– – ﹤0.01% 3762
2016
Q4 		$0 Hold
137
– – ﹤0.01% 3770
2016
Q3 		$0 Hold
137
– – ﹤0.01% 3768
2016
Q2 		$0 Buy
+137
New +$71 ﹤0.01% 3804

US Bancorp's AST.WS Position: Q3 2017 in Review

US Bancorp sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 137 shares.

US Bancorp first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • US Bancorp reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • US Bancorp sold 137 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • US Bancorp first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • US Bancorp's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on US Bancorp's 13F filing for Q3 2017, filed 13 Nov 2017.